Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma

ClinicalTrials.gov ID: NCT00393952

Public ClinicalTrials.gov record NCT00393952. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel Group, Stratified, Multi-center, 12-Week Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm(tm) 100/10 µg or 250/10 µg Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI) With the Administration of Placebo or Fluticasone (250 µg Twice Daily) and Formoterol (10 µg Twice Daily) Alone in Adolescent and Adult Patients With Moderate to Severe Asthma

Study identification

NCT ID
NCT00393952
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
SkyePharma AG
Industry
Enrollment
557 participants

Conditions and interventions

Conditions

Interventions

  • Fluticasone propionate/Formoterol fumarate 250/10 Drug
  • Placebo Drug
  • Fluticasone propionate/Formoterol fumarate 100/10 Drug
  • Fluticasone propionate 250 Drug
  • Formoterol fumarate 10 Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Mar 31, 2008
Completion
Mar 31, 2008
Last update posted
Jun 22, 2011

2006 – 2008

United States locations

U.S. sites
62
U.S. states
26
U.S. cities
56
Facility City State ZIP Site status
Research Center Pell City Alabama 35128
Research Site Glendale Arizona 85306
Research Center Phoenix Arizona 85050
Research Site Phoenix Arizona 85050
Research Site Tucson Arizona 85712
Research Site Jonesboro Arkansas 72401
Research Site Little Rock Arkansas 72205
Research Site Burbank California 91505
Research Site Fresno California 93720
Research Site Long Beach California 90806
Research Site Los Angeles California 90025
Research Center Los Angeles California 90048
Research Site Los Angeles California 90048
Research Site Mission Viejo California 92691
Research Site Monterey Park California 91754
Research Site Palmdale California 93551
Research Site Sacramento California 95819
Research Site San Diego California 92120
Research Site San Diego California 92123
Research Site San Jose California 95128
Research Center Gainesville Florida 32605
Research Site Hialeah Florida 33013
Research Site Ormond Beach Florida 32174
Research Center Panama City Florida 32405
Research Site Pensacola Florida 32503
Research Site Tampa Florida 33613
Research Center Congers Georgia 30012
Research Site Savannah Georgia 31406
Research Site Round Lake Beach Illinois 60073
Research Site Louisville Kentucky 40215
Research Site Baltimore Maryland 21236
Research Site North Dartmouth Massachusetts 02747
Research Site Taunton Massachusetts 02780
Research Center Minneapolis Minnesota 55402
Research Site Minneapolis Minnesota 55402
Research Site Plymouth Minnesota 55441
Research Site St Louis Missouri 63141
Research Site Bozeman Montana 59718
Research Site Omaha Nebraska 68130
Research Site Las Vegas Nevada 89123
Research Site Brick New Jersey 08724
Research Site Mount Laurel New Jersey 08054
Research Site Skillman New Jersey 08558
Research Site Tinton Falls New Jersey 07001
Research Site Rockville Centre New York 11570
Research Site Oklahoma City Oklahoma 73139
Research Site Ashland Oregon 97520
Research Site Medford Oregon 97504
Research Center Portland Oregon 97213
Research Center Upland Pennsylvania 19013
Research Site Lincoln Rhode Island 02865
Research Center Anderson South Carolina 29621
Research Site Greenville South Carolina 29607
Research Site Austin Texas 78750
Research Site Dallas Texas 75231
Research Site El Paso Texas 79902
Research Center Fort Worth Texas 76104
Research Site San Antonio Texas 72205
Research Site San Antonio Texas 78229
Research Site Richmond Virginia 23225
Research Site Tacoma Washington 98405
Research Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00393952, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2011 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00393952 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →